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Gastric cancer (GC) is an aggressive and heterogeneous disease with poor survival. The most common type of GC is 
adenocarcinoma, which can be divided into two subtypes: intestinal and diffuse, according to the Laurén classification. Both 
intestinal and diffuse-types GC are associated with Helicobacter pylori (H. pylori) infection. However, in intestinal-type GC this 
infection usually progresses to invasive carcinoma through the appearance of pre-neoplastic lesions: atrophic gastritis and 
intestinal metaplasia. Intestinal metaplasia (IM) is histologically classified into two subtypes: the complete (CIM) and the incomplete 
 
  
(IIM) lesions and both subtypes of IM can progress to GC, thus the investigation of deregulated genes and molecular process 
responsible for this transformation is relevant. Previously, the TULP3 transcription factor was identified as a possible prognostic 
biomarker in pancreatic ductal adenocarcinoma. Considering that pancreatic and gastric tissues have the same embryonic origin, 
we investigated the profile of TULP3 expression in gastric tissues hypothesizing that it may have a role in gastric diseases. We 
comparatively analyzed TULP3 expression in different gastric tissues through the in gene expression data publicly available using 
bioinformatics tools, and we verified TULP3 gene expression association with patient survival in GC. We found a significant 
statistical difference between groups in GSE2669 study (p-value=3.435e-05), in which non-tumoral gastric lesions have similar 
TULP3 gene expression (ChG median=0.152 and IM median=0.158). We also observed in GSE78523 study higher TULP3 levels in 
incomplete IM subtype that progressed to GC (IIM-GC) in comparison to complete IM that progressed and did not progressed to 
GC (CIM-GC and CIM-nonGC) with a significant statistical difference (p-value=2.488e-03). The IM lesion is characterized by the 
replacement of gastric mucosa normal epithelium to an intestinal one and the incomplete (IIM) subtype is more likely to progress to 
GC than the complete (CIM). Thus, the TULP3 gene expression in the progression from intestinal metaplasia to gastric carcinoma 
indicates a possible role as risk biomarker for developing gastric cancer. Palavras-chaves: gastric cancer, intestinal metaplasia, 
TULP3  
